Martin Fauda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Martin Fauda has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Oscar Andriani
Sanatorio Los Arcos, Buenos Aires
2 shared publications - Pablo Barros Schelotto
Cirugía Hepatobiliar y Trasplante Multiorgánico, Hospital Universitario Fundación Favaloro, Caba, Argentina
2 shared publications - A. Gonzalez Campaña
HPB Surgery and Liver Transplantation, Hospital Universitario Austral, Argentina
1 shared publication - Dario Teran
Cirugía Hepatobiliar y Trasplante Multiorgánico, Hospital Universitario Fundación Favaloro, Caba, Argentina
1 shared publication E. Huertas
Instituto Alexander Fleming, Caba, Argentina
1 shared publicationE.A. Silberman
HPB Surgery and Liver Transplantation, Hospital Universitario Austral, Argentina
1 shared publication
Latest Publications
- Open Access
- 13 September 2022
- Published by Wolters Kluwer Health in Transplantation
- Vol. 106 (9S) , S350-S351
346.3: Liver Transplantation for Metastatic Neuroendocrine Tumor in Argentina: Outcomes From a Multicenter Study
- 13 September 2022
- Published by Wolters Kluwer Health in Transplantation
- Vol. 106 (9S) , S350-S351
Open Access346.3: Liver Transplantation for Metastatic Neuroendocrine Tumor in Argentina: Outcomes From a Multicenter Study
- Open Access
- 20 June 2018
- Published by Elsevier in Annals of Oncology
- Vol. 29 (suppl_5) , v76
Prognostic impact of K-RAS mutational status and primary tumour location in patients undergoing resection for colorectal cancer liver metastases: A METHEPAR analysis (multicentre study in Argentina)
Introduction: Even though RAS mutations are known to imply aggressive tumour biology, their objective impact on survival is still controversial. The purpose of this study is to determine the impact of KRAS mutational status in the overall survival (OS) and recurrence free survival (RFS) of patients undergoing surgery for colorectal liver metastases (CLM).
- 20 June 2018
- Published by Elsevier in Annals of Oncology
- Vol. 29 (suppl_5) , v76
Open AccessPrognostic impact of K-RAS mutational status and primary tumour location in patients undergoing resection for colorectal cancer liver metastases: A METHEPAR analysis (multicentre study in Argentina)
Introduction: Even though RAS mutations are known to imply aggressive tumour biology, their objective impact on survival is still controversial. The purpose of this study is to determine the impact of KRAS mutational status in the overall survival (OS) and recurrence free survival (RFS) of patients undergoing surgery for colorectal liver metastases (CLM).